Skip to main content

Amanda DiNofia, MD

Amanda DiNofia, MD

Amanda DiNofia, MD

Amanda DiNofia, MD, is an Attending Physician in the Cancer Center and a member of the Center Childhood Cancer Research at Children's Hospital of Philadelphia.

Areas of expertise: Immunotherapy


215-590-3025

267-426-0762

About Amanda DiNofia, MD

Titles

Attending Physician

Assistant Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania

Certifications

Pediatric Hematology-Oncology – American Board of Pediatrics

Pediatrics – American Board of Pediatrics

Awards and Honors

2016, Finalist, American Society of Hematology Research Training Fellow Award for Fellows
2014, Abstract Achievement Award, American Society of Hematology Meeting and Exposition
2014, Selected to represent fellowship class, The Children's Hospital of Philadelphia
2013, Excellence in Medical Student Education Award, Children’s National Medical Center
2012, The Doctor Maynard I. Cohen Memorial Award, Children’s National Medical Center
2012, Excellence in Medical Student Education Award, Children’s National Medical Center
2012, Coleman International Travel Grant, Children’s National Medical Center
2011, Excellence in Emergency Medicine, Children’s National Medical Center
2010, Excellence in Medical Student Education Award, Children’s National Medical Center
2004, Excellence in Medical Student Education Award, Children’s National Medical Center
2001, Leadership Scholar, Ursinus College
2000, Valedictorian, Archbishop Prendergast High School

Leadership and Memberships

Memberships in Professional Organizations

2018 - present, American Society of Blood and Marrow Transplantation
2014 – present, American Society of Hematology

Education & training

Graduate Degree

MS in Clinical Epidemiology (MSCE) - University of Pennsylvania, Philadelphia, PA

Medical Degree

MD - Drexel University College of Medicine, Philadelphia, PA

Residency

Pediatrics - Children's National Medical Center, Washington, DC (Chief Resident)

Fellowship

Pediatric Pharmacoepidemiology Research - The Children's Hospital of Philadelphia, Philadelphia, PA
Pediatric Hematology/Oncology - The Children's Hospital of Philadelphia, Philadelphia, PA

Publications

Publications

2016

DiNofia, A.M., Wang, X., Yannekis, G., Ogle, S., Hobbie, W.L., Carlson, C.A., Ginsberg, J.P. Analysis of semen parameters in a young cohort of cancer patients. Pediatric Blood and Cancer. 2016. Advance online publication. doi: 10.1002/pbc.26221.

DiNofia, A.M., Salazar, E., Seif, A.E., Li, Y., Huang, Y.S., Bagatell, R., Fisher, B.T., Aplenc, R. Bortezomib inpatient prescribing practices in free-standing children’s hospitals in the United States. PLoS One. 2016; 11(3):e0151362. doi: 10.1371/journal.pone.0151362.

2013

Sadak, K., DiNofia, A., Reaman. G. Patient-perceived facilitators to the transition of survivorship care from the pediatric to the adult care-setting. Pediatric Blood and Cancer. 2013; 60(8):1365-8.

Abstracts (includes Posters and Scientific Presentations)

Research Presentations

2015

K. Sadak, A. DiNofia, K. Shafer, K. Steacy. Parent perceptions on the transition of childhood cancer survivorship care from the pediatric to adult-care setting. Poster Presentation at the Long-Term Complications of Treatment of Children and Adolescents for Cancer, Arlington, VA, June 2015.

2014

A. DiNofia, A. Seif, M. Devidas, et al. Resource utilization and cost analysis by treatment arm on the phase 3 high-risk B-precursor acute lymphoblastic leukemia trial AALL0232: a report from the Children's Oncology Group. Oral Presentation at 56th Annual American Society of Hematology Meeting and Exposition, December 2014.

Lectures by Invitation

2015

A. DiNofia. The use of merged PHIS datasets in epidemiologic studies. Children's Hospital Association's Pediatric Analytics Conference. Kansas City, MO. September 2015.

2014

A. DiNofia, A. Seif, M. Devidas, et al. Resource utilization and cost analysis by treatment arm on the phase 3 high-risk B precursor acute lymphoblastic leukemia trial AALL0232: a report from the Children’s Oncology Group. Oral Presentation at 56th Annual American Society of Hematology Meeting and Exposition, December 2014.

Jump back to top